AI assistant
Sending…
Cellectis — Share Issue/Capital Change 2025
Jan 8, 2025
1190_dva_2025-01-08_a2df2f6b-2d47-4fb4-a0b4-167ba16ffb11.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority)
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital |
Total number of voting rights |
|---|---|---|
| 12/31/2024 | 100,093,873 | 88,660,539 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, [email protected] Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, [email protected]
More from Cellectis
Foreign Filer Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Foreign Filer Report
2026
May 11
Interim / Quarterly Report
2026
May 11
Earnings Release
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 6
Declaration of Voting Results & Voting Rights Announcements
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4